tykhr
sign in
free sign up
Silverback Therapeutics Inc
Biotechnology
Healthcare
SBTX
35.11 M shares
NASDAQ US
traded
09 Nov 2022
listed
yes
open
26.00
52 week high
25.50
high
26.50
52 week low
2.90
low
25.16
growth
210.22 %
previous Close
5.87
P/E ratio
market cap
161 M
div yield
0
usd
Mar 2022
qoq
revenue
0.00 %
net incoming
-24.63 M
-4.99 %
eps
0.00 %
-4.48 %
eps surprise
-29.63 %
net profit margin
-2463100000.00 %
0.00 %
operating incoming
-24.70 M
-5.07 %
net change in cash
-20.06 M
57.07 %
cash on hand
234 M
-7.89 %
cost of revenue
0.00 %
top